HuagongsheHuagongshe Chemistry Print Report · For research reference only
2-Bromoisovaleric acid → 2-Bromo-1-(4-(4-chlorophenyl)piperidin-1-yl)-3-methylbutan-1-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2-Bromoisovaleric acid | HCID 11268 | — |
| Reactant | 1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide | HCID 15908 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | 4-(4-chlorophenyl)piperidine Hydrochloride | HCID 2757843 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 2-Bromo-1-(4-(4-chlorophenyl)piperidin-1-yl)-3-methylbutan-1-one | HCID 57889673 | 85% |
Reaction Steps
A mixture of 2-bromo-3-methylbutanoic acid (14) (400 mg, 2.2 mmol), 4-(4-chlorophenyl)-piperidine hydrochloride (500 mg, 2.2 mmol), HOBt (300 mg, 2.2 mmol) and EDCI (425 mg, 2.2 mmol) was suspended in DMF (10 mL). DIEA (1.4 mL, 8 mmol) was added and the reaction was stirred overnight. After this time, the reaction was diluted with Et2O (100 mL) and washed sequentially with H2O (2×40 mL); aqueous 1N HCl (2×20 mL); aqueous sat. NaHCO3 (1×20 mL) solution and aqueous sat. NaCl (1×20 mL) solution. The Et2O layer was dried (MgSO4), and the solvents were removed to give 2-bromo-1-(4-(4-chlorophenyl)piperidin-1-yl)-3-methylbutan-1-one (600 mg, 85%) as an impure oil, which was used without purification. MS found: 360 (M+H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07985861B2 |
| Source dataset | uspto-grants-2011_07 |
| ORD ID | ord-b50da7b920fc4c96a55c23143d0e00f6 |
| Source note | uspto-grants-2011_07 |